Shire to participate at two upcoming investor conferences
Shire to participate at two upcoming investor conferences
Lexington, MA, USA – September 8, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming Ornskov, MD, Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference on September 12, 2016 at 3:40 p.m. EDT (8:40 p.m. BST) and Jeff Poulton, Chief Financial Officer will present at the Bank of America Merrill Lynch Global Healthcare Conference 2016 on September 16, 2016 at 11:25 a.m. BST (6:25 a.m. EDT).
The live audio webcasts of both events will be available on the Presentations and Webcasts section of Shire's Investor website at http://investors.shire.com/presentations-and-webcasts/. Subsequently, a replay of both events will be available on this same website.
For further information please contact:
|
Investor Relations |
|
|
|
Sarah Elton-Farr |
+44 1256 894157 | |
|
Ian Karp |
+1 781 482 9018 | |
|
Robert Coates |
+44 1256 894874 |
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.